Recombinant Human Insulin-like Growth Factor as a Therapeutic Agent for Severe Insulin Resistance and Type Η Diabetes Mellitus

Articles in the same Issue

1. CONTENTS
2. Preface
3. The IGF-Insulin Relationship
4. Interaction between IGF-I, Insulin and Growth Hormone in Type II Diabetes
5. Insulin Resistance in Laron Syndrome (Primary Insulin-like Growth Factor-I (IGF-I) Deficiency) and Effect of IGF-I Replacement Therapy
6. How does rhIGF-I Replacement Improve Insulin Sensitivity in Insulin Dependent Diabetes Mellitus?
7. Recombinant Human Insulin-like Growth Factor as a Therapeutic Agent for Severe Insulin Resistance and Type Η Diabetes Mellitus
8. The Use of Growth Hormone and Insulin-like Growth Factor-I in Catabolic States
9. GH and IGF-I in Lipoprotein Metabolism
10. Opposing Effects of Growth Hormone and Insulin-like Growth Factor I on Serum Lipoprotein(a)
11. Effects of Growth Hormone Replacement Therapy on Glucose Metabolism are Due to Changes of Body Composition